Delcath Systems adds new clinical sites for FOCUS trial to treat ocular melanoma liver metastases

Delcath Systems has announced that five new clinical trial sites in the US have been added to its global FOCUS Phase 3 clinical trial for patients with hepatic dominant ocular melanoma.

Source: Drug Development Technology - October 11, 2016 Category: Pharmaceuticals Source Type: news